Beam Therapeutics Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Beam Therapeutics Inc. (BEAM) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 16.07 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-04
- Beam Therapeutics Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 16.09M shares, a 9.48% increase year-over-year.
- Beam Therapeutics Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 14.70M shares, a 9.90% increase year-over-year.
- Beam Therapeutics Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 13.37M shares, a 20.92% increase year-over-year.
- Beam Therapeutics Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 11.06M shares, a 25.58% increase year-over-year.
- Beam Therapeutics Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 13.96M shares, a 13.91% increase from fiscal 2024.
- Beam Therapeutics Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 12.26M shares, a 8.68% increase from fiscal 2023.
- Beam Therapeutics Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 11.28M shares, a 21.42% increase from fiscal 2022.
- Beam Therapeutics Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 9.29M shares, a 29.35% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | 16.07M shares 10-Q · filed 2026-08-04 | |||
| 2026-03-31 | 16.09M shares 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | 13.96M shares 10-K · filed 2026-02-24 | |||
| 2025-09-30 | 14.33M shares 10-Q · filed 2025-11-04 | |||
| 2025-06-30 | 14.63M shares 10-Q · filed 2026-08-04 | |||
| 2025-03-31 | 14.70M shares 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | 12.26M shares 10-K · filed 2026-02-24 | |||
| 2024-09-30 | 13.26M shares 10-Q · filed 2025-11-04 | |||
| 2024-06-30 | 13.55M shares 10-Q · filed 2025-08-05 | |||
| 2024-03-31 | 13.37M shares 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | 11.28M shares 10-K · filed 2026-02-24 | |||
| 2023-09-30 | 10.91M shares 10-Q · filed 2024-11-05 | |||
| 2023-06-30 | 11.09M shares 10-Q · filed 2024-08-06 | |||
| 2023-03-31 | 11.06M shares 10-Q · filed 2024-05-07 | |||
| 2022-12-31 | 9.29M shares 10-K · filed 2025-02-25 | |||
| 2022-09-30 | 9.25M shares 10-Q · filed 2023-11-08 | |||
| 2022-06-30 | 9.08M shares 10-Q · filed 2023-08-08 | |||
| 2022-03-31 | 8.81M shares 10-Q · filed 2023-05-10 | |||
| 2021-12-31 | 7.18M shares 10-K · filed 2024-02-27 | |||
| 2021-09-30 | 7.43M shares 10-Q · filed 2022-11-07 | |||
| 2021-06-30 | 7.23M shares 10-Q · filed 2022-08-09 | |||
| 2021-03-31 | 7.50M shares 10-Q · filed 2022-05-09 | |||
| 2020-12-31 | 6.61M shares 10-K · filed 2023-02-28 | |||
| 2020-09-30 | 7.13M shares 10-Q · filed 2021-11-08 | |||
| 2020-06-30 | 7.53M shares 10-Q · filed 2021-08-10 | |||
| 2020-03-31 | 7.93M shares 10-Q · filed 2021-05-11 | |||
| 2019-12-31 | 36.57M shares 10-K · filed 2022-02-28 | |||
| 2019-09-30 | 37.11M shares 10-Q · filed 2020-11-10 | |||
| 2019-06-30 | 37.01M shares 10-Q · filed 2020-08-12 | |||
| 2019-03-31 | 36.12M shares 10-Q · filed 2020-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |